These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20926323)

  • 1. Reversible magnetic resonance imaging and spectroscopy abnormalities in the course of vigabatrin treatment for West syndrome.
    Thelle T; Gammelgaard L; Hansen JK; Østergaard JR
    Eur J Paediatr Neurol; 2011 May; 15(3):260-4. PubMed ID: 20926323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral MRI abnormalities associated with vigabatrin therapy.
    Pearl PL; Vezina LG; Saneto RP; McCarter R; Molloy-Wells E; Heffron A; Trzcinski S; McClintock WM; Conry JA; Elling NJ; Goodkin HP; de Menezes MS; Ferri R; Gilles E; Kadom N; Gaillard WD
    Epilepsia; 2009 Feb; 50(2):184-94. PubMed ID: 18783433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are vigabatrin induced T2 hyperintensities in cranial MRI associated with acute encephalopathy and extrapyramidal symptoms?
    Dill P; Datta AN; Weber P; Schneider J
    Eur J Paediatr Neurol; 2013 May; 17(3):311-5. PubMed ID: 23199677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vigabatrin-associated reversible MRI signal changes in patients with infantile spasms.
    Dracopoulos A; Widjaja E; Raybaud C; Westall CA; Snead OC
    Epilepsia; 2010 Jul; 51(7):1297-304. PubMed ID: 20384718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy.
    Wheless JW; Carmant L; Bebin M; Conry JA; Chiron C; Elterman RD; Frost M; Paolicchi JM; Donald Shields W; Thiele EA; Zupanc ML; Collins SD
    Epilepsia; 2009 Feb; 50(2):195-205. PubMed ID: 19054414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An investigation into the relationship between vigabatrin, movement disorders, and brain magnetic resonance imaging abnormalities in children with infantile spasms.
    Fong CY; Osborne JP; Edwards SW; Hemingway C; Hancock E; Johnson AL; Kennedy CR; Kneen R; Likeman M; Lux AL; Mordekar SR; Murugan V; Newton RW; Pike M; Quinn M; Spinty S; Vassallo G; Verity CM; Whitney A; O'Callaghan FJ
    Dev Med Child Neurol; 2013 Sep; 55(9):862-7. PubMed ID: 23789722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vigabatrin-induced MRI changes associated with extrapyramidal symptoms in a child with infantile spasms.
    Schonstedt V; Stecher X; Venegas V; Silva C
    Neuroradiol J; 2015 Oct; 28(5):515-8. PubMed ID: 26306928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vigabatrin in infantile spasms: preliminary result.
    Visudtibhan A; Chiemchanya S; Visudhiphan P; Phusirimongkol S
    J Med Assoc Thai; 1999 Oct; 82(10):1000-5. PubMed ID: 10561962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Globus pallidus restricted diffusion associated with vigabatrin therapy.
    Trindade RAR; Wainstein B; Campos LG; Pérez JA; Bianchin MM; Vedolin LM; Duarte JÁ
    Arq Neuropsiquiatr; 2018 Feb; 76(2):127-128. PubMed ID: 29489970
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk of vigabatrin-associated brain abnormalities on MRI in the treatment of infantile spasms is dose-dependent.
    Hussain SA; Tsao J; Li M; Schwarz MD; Zhou R; Wu JY; Salamon N; Sankar R
    Epilepsia; 2017 Apr; 58(4):674-682. PubMed ID: 28230253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological evidence of vacuolar myelinopathy in a child following vigabatrin administration.
    Horton M; Rafay M; Del Bigio MR
    J Child Neurol; 2009 Dec; 24(12):1543-6. PubMed ID: 19773459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of West syndrome].
    Cvitanović-Sojat L; Gjergja R; Sabol Z; Hajnzić TF; Sojat T
    Acta Med Croatica; 2005; 59(1):19-29. PubMed ID: 15813352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vigabatrin administration in patients with infantile spasms: the risks.
    Jaseja H
    Clin Neurol Neurosurg; 2010 Nov; 112(9):835. PubMed ID: 20934097
    [No Abstract]   [Full Text] [Related]  

  • 14. The vigabatrin-associated brain abnormalities on MRI and their differential diagnosis.
    Corrêa DG; Telles B; Freddi TAL
    Clin Radiol; 2024 Feb; 79(2):94-101. PubMed ID: 38092645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vigabatrin as a first-choice drug in the treatment of West syndrome.
    Fejerman N; Cersósimo R; Caraballo R; Grippo J; Corral S; Martino RH; Martino G; Aldao M; Caccia P; Retamero M; Macat MC; Di Blasi MA; Adi J
    J Child Neurol; 2000 Mar; 15(3):161-5. PubMed ID: 10757471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vigabatrin therapy in infantile spasms.
    Kankirawatana P; Raksadawan N; Balangkura K
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S778-83. PubMed ID: 12403260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of West syndrome with vigabatrin: reversible MRI signal changes.
    Carvalho Neto Ad; Coelho LO; Ono SE; Crippa AC
    Arq Neuropsiquiatr; 2011 Dec; 69(6):998. PubMed ID: 22297900
    [No Abstract]   [Full Text] [Related]  

  • 18. Transient brain magnetic resonance imaging hyperintensity in basal ganglia and brain stem of epileptic infants treated with vigabatrin.
    Milh M; Villeneuve N; Chapon F; Pineau S; Lamoureux S; Livet MO; Bartoli C; Hugonenq C; Mancini J; Chabrol B; Girard N
    J Child Neurol; 2009 Mar; 24(3):305-15. PubMed ID: 19258289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vigabatrin for infantile spasms.
    Pesaturo KA; Spooner LM; Belliveau P
    Pharmacotherapy; 2011 Mar; 31(3):298-311. PubMed ID: 21361740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vigabatrin in the treatment of infantile spasms.
    Vles JS; van der Heyden AM; Ghijs A; Troost J
    Neuropediatrics; 1993 Aug; 24(4):230-1. PubMed ID: 8232783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.